Company Overview of Avila Therapeutics, Inc.
Avila Therapeutics, Inc. designs and develops covalent drugs for viral infections, cancers, and autoimmune diseases. It offers AVL-181, a small molecule hepatitis C virus protease inhibitor. Avila Therapeutics, Inc. has a strategic alliance with Sanofi-Aventis. The company was incorporated in 2006 and is based in Waltham, Massachusetts. As of March 7, 2012, Avila Therapeutics, Inc. operates as a subsidiary of Celgene Corporation.
100 Beaver Street
Waltham, MA 02453-8425
Founded in 2006
Key Executives for Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Intendis, Inc.||United States|
|Psylin Neurosciences, Inc.||United States|
|Oncology Research Therapeutics||United States|
|Koloseum Nutritional Sciences, Inc.||United States|
|Apovia, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Apr 15
- Florham Park, NJ | PwCPosted: Aug 20
- Chicago, IL | PwCPosted: Aug 20
- New York, NY | PwCPosted: Aug 20
Sponsored Financial Commentaries
To contact Avila Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.